| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | S100A8 and S100A9 in inflammation and cancer. | Biochem Pharmacol | 2006 | 3.67 |
| 2 | RAGE signaling sustains inflammation and promotes tumor development. | J Exp Med | 2008 | 2.51 |
| 3 | The receptor RAGE: Bridging inflammation and cancer. | Cell Commun Signal | 2009 | 1.20 |
| 4 | Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface. | Cancer Immunol Immunother | 2006 | 0.84 |
| 5 | Identification of the Rage-dependent gene regulatory network in a mouse model of skin inflammation. | BMC Genomics | 2010 | 0.81 |
| 6 | Hepatocyte-specific S100a8 and S100a9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment. | Cell Commun Signal | 2012 | 0.78 |